Contact this trialFirst, we need to learn more about you.
Chemotherapy
Pembrolizumab + Chemotherapy for Brain Metastases from Lung Cancer
Recruiting1 awardPhase 2
Lexington, Kentucky
This trial will test whether the drug Pembrolizumab can help people with NSCLC and untreated brain metastasis live longer with fewer side effects.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.